Checked against public sources on August 10, 2026 · LookCloser does not sell or recommend supplements.
Does the marketing hold up?
FDA recall appears in this brand's history. An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.
“Couldn’t verify” means we looked and found no public proof — not a mark against the product. Most supplement claims cannot be independently verified by anyone, so grey is the normal state of this industry.
| Vitamin D3 (as Cholecalciferol) (1500/3000 IU) | 38 mcg |
|---|---|
| Magnesium (as Magnesium Bisglycinate) | 20 mg |
| Zinc (as Zinc Bisglycinate Chelate) | 15 mg |
| Fadogia Agrestis Extract (10:1) (root) | 300 mg |
| Tongkat Ali Extract (Eurycoma longifolia) (root) (standardized to 1% Eurycomanone) | 300 mg |
| Ashwagandha Extract (KSM-66®) (Withania somnifera) (root) (standardized to 5% Withanolides) | 250 mg |
| Boron (as Boron Citrate) | 5 mg |
Printed on the package: Third Party Tested
We read 7 lines from the package photograph. It is our transcript of the label, not the manufacturer’s panel, and it may be incomplete.
1 promise needs a closer look.
Published research exists for ingredients in this formula. Whether this product’s doses match those studies could not be confirmed.
Ingredient research can support context, but it is not a trial of this exact product.
We found no named, citable study of this product or formula. The claim may rest on ingredient research rather than a trial of this product.
No named laboratory or lot-specific certificate was found for this exact product. No exact brand product page was available for a document check. NSF, IFOS, USP, and Informed-Sport were not checked in this record. This is a public-evidence limit, not a finding that testing did not occur.
We looked and found no public proof. That does not count against the product.
Headlines first. Open evidence only when you want the source trail.
An exact-product recall is a direct signal. A different product from the same firm is company context, not a strike against this item.
This recall is not about the product on this page. Gorilla Mind LLC recalled a different product on September 6, 2024. FDA has since closed that case. The recalled item was “Gorilla Mind Rauwolscine Dietary Supplement, Suppress Appetite, Increased Fat Loss, Increased Energy…”
Locked evidence record →Open the full source-linked findingThis is category history, not proof about this product, but it changes how much unsupported claims deserve to be trusted.
FDA's health-fraud program documents sexual-enhancement products as the most common supplement category found to contain undeclared prescription-drug ingredients. This is a category-level documented fact from FDA's public database — not a test result for this specific product. …
Locked evidence record →Open the full source-linked findingEvery ingredient shows its real amount — nothing is hidden in a proprietary blend.
The panel gives a per-ingredient amount rather than hiding quantities inside a proprietary blend, so each one can be compared to published research.
Locked evidence record →Open the full source-linked findingThe barcode matches, so we are checking the right product rather than a look-alike.
Open Food Facts resolves 850017020689 to "Sigma Test Booster" (Gorilla Mode) — consistent with this listing.
Locked evidence record →Open the full source-linked findingThese are evidence gaps, not strikes against the product.
Filed address
2145 E Pine Ave, Meridian, Idaho 83642, UNITED STATES
USPTO identifies the public owner or applicant behind this brand wordmark. This does not by itself identify the product manufacturer or prove where the product was made. Open USPTO source ↗
We could not match an amount on this product to a studied range for the same ingredient, so these links are ingredient background rather than a measurement of this product.
Not a score. Studies disagree with each other and change over time, so this sits beside the evidence rather than counting toward it — it is here so you can read the sources yourself.
The panel lists 20 mg of magnesium per serving. Studies we found used 200 mg–420 mg a day, so this sits below that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
The panel lists 250 mg of ashwagandha per serving. Studies we found used 250 mg–600 mg a day, so this sits inside that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
The panel lists 5 mg of boron per serving. Studies we found used 3 mg–10 mg a day, so this sits inside that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
The panel lists 300 mg of tongkat ali (Eurycoma longifolia) per serving. Studies we found used 200 mg–400 mg a day, so this sits inside that range.
Study ranges differ between trials and change as research changes. This is background reading, not a pass, a failure, or a recommendation.
$0.71 per labeled serving
matching UPC/GTIN · checked Aug 10, 2026
View on Amazon ↗We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search iHerb ↗We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Target ↗We only show a price when the seller publishes the same barcode as the bottle. We haven’t found that match here.
Search Walmart ↗Only one exact price was available at build time; prices change by date, seller, and promotion.
Reference prices only · no affiliate links · every compared seller must publish the matching UPC/GTIN.
The full report shows every source, the exact unresolved question, and the documentation that would settle it.
Record built August 10, 2026. Sources: source listing observed at check time · USPTO Trademark Search · Keepa exact-listing history · NIH / published research · certification and regulator records where available. LookCloser publishes evidence and gaps; it does not advise for or against any supplement. Evidence-based corrections welcome.